MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu(The University of Texas MD Anderson Cancer Center), Ken H. Young(Duke Medical Center), Karen Dybkær(Aalborg University Hospital), Weina Chen(Army Medical University), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Aarthi Balasubramanyam(Materials Systems (United States)), Wei-min Liu(Materials Systems (United States)), Eric D. Hsi(Mayo Clinic), Ronald S. Go(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Randy D. Gascoyne(BC Cancer Agency), Zijun Y. Xu‐Monette(Duke University), Qin Huang(City Of Hope National Medical Center), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Weiyun Z. Ai(University of California, San Francisco), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Graham W. Slack(BC Cancer Agency), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Tina Green(Hospital South West Jutland), Youli Zu(Methodist Hospital), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Lin Wu(Materials Systems (United States)), Jooryung Huh(Asan Medical Center), Yong Li(Baylor College of Medicine), Fan Zhou(Southwest Washington Medical Center), Xiaoying Zhao(Second Affiliated Hospital of Zhejiang University), William W.L. Choi(Chinese University of Hong Kong), Meifeng Tu(Peking University), L. Jeffrey Medeiros(Delaware Division of Libraries), Daina Variakojis(Northwestern University), Michael Møller(Hospital South West Jutland)
Cited by 677
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k